Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
83.55
+0.26 (0.31%)
Oct 1, 2026, 3:10 PM EDT - Market open
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $165 | Buy | Maintains | $165 | +97.49% | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +43.63% | Sep 24, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $175 | Buy | Maintains | $175 | +109.46% | Sep 23, 2026 |
| Clear Street | Clear Street | Buy Maintains $131 | Buy | Maintains | $131 | +56.79% | Sep 23, 2026 |
| Barclays | Barclays | Buy Maintains $160 | Buy | Maintains | $160 | +91.50% | Sep 21, 2026 |
| UBS | UBS | Buy Maintains $130 | Buy | Maintains | $130 | +55.60% | Sep 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +115.44% | Aug 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.